Company profile
Eloxx Pharmaceuticals, Inc. Insider Trading
ELOXEvery SEC Form 4 insider trading filing for Eloxx Pharmaceuticals, Inc. (ELOX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- OTC
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001035354
- Filings
- 23
- Insiders
- 8
- Last filing
- 2026-06-10
Activity summary
No insider transactions in the last 30 days. The most recent was on June 10, 2026, when Domicilium Real Estate Fund III LP sold 238,422 shares. 23 filings from 8 insiders are on record below.
Quarterly balance
Buy and sell value by quarter, Q1 22 to Q2 26. Eloxx Pharmaceuticals, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $39K.
90 day insight
Over the last 90 days, Eloxx Pharmaceuticals, Inc. insiders bought $0 across 5 transactions with no open-market sales.
- Most active insider: Domicilium Real Estate Fund III LP with 6 transactions totaling $0.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Domicilium Real Estate Fund III LP | ELOX | J | 238,422 | — | — |
| Jun 10, 2026 | Domicilium Real Estate Fund III LP | ELOX | J | 238,422 | — | — |
| Jun 10, 2026 | Domicilium Real Estate Fund III LP | ELOX | J | 361,578 | — | — |
| Jun 10, 2026 | Aggarwal Sumit | ELOX | Award | 328,833 | — | — |
| Jun 10, 2026 | Domicilium Real Estate Fund III LP | ELOX | J | 361,578 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ELOX" \
-H "X-Api-Key: $KEY"